Position in DMRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$59,857,023
New position
Shares Held
2,311,082
first reported quarter
Ownership
3.75%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026VIKING GLOBAL INVESTORS LP holds $2,367,311,049 across 15 Biotechnology names. DMRA ranks #11 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
11,842,434 | $879,419,148 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
7,062,077 | $398,936,729 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,652,448 | $184,272,809 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
4,203,567 | $134,556,179 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
2,666,690 | $130,801,144 | |
| 6 | SION |
Sionna Therapeutics, Inc.
|
3,195,181 | $128,094,806 | |
| 7 | MANE |
Veradermics, Inc
|
1,690,555 | $106,758,548 | |
| 8 | PHVS |
Pharvaris N.V.
|
3,653,310 | $103,206,007 |
All Filings in DMRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,857,023 | 2,311,082 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||